Ceftazidime- and imipenem-induced endotoxin release during treatment of gram-negative infections

Eur J Clin Microbiol Infect Dis. 2001 Nov;20(11):804-7. doi: 10.1007/s100960100609.

Abstract

To determine whether ceftazidime and imipenem, which target two different penicillin-binding proteins, result in different amounts of endotoxin and cytokine release in patients with gram-negative infection, plasma endotoxin, interleukin-6, and tumor necrosis factor alpha were measured during the first 24 h of antibiotic therapy in 27 patients with gram-negative infection who had been randomized to receive either ceftazidime 2 g t.i.d. (n=12) or imipenem/cilastatin 1 g t.i.d. (n=15). The source of infection was the digestive tract (n=13), the urinary tract (n=5), the respiratory tract (n=2), soft tissue (n=2), i.v. line (n=2), or other (n=3). After the first antibiotic injection, a significant increase in the median concentration of plasma interleukin-6 and plasma tumor necrosis factor alpha was noted, without significant differences related to the antibiotic administered. Antibiotic-induced endotoxemia was detectable in nine patients (including 7 with bacteremia). In conclusion, ceftazidime and imipenem had similar effects on endotoxin and cytokine release during the treatment of gram-negative infections.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bacteremia / blood
  • Bacteremia / drug therapy
  • Ceftazidime / administration & dosage*
  • Drug Administration Schedule
  • Endotoxins / blood*
  • Female
  • Gram-Negative Bacterial Infections / blood
  • Gram-Negative Bacterial Infections / drug therapy
  • Humans
  • Imipenem / administration & dosage*
  • Injections, Intravenous
  • Interleukin-6 / blood*
  • Male
  • Probability
  • Reference Values
  • Sensitivity and Specificity
  • Statistics, Nonparametric
  • Tumor Necrosis Factor-alpha / analysis*

Substances

  • Endotoxins
  • Interleukin-6
  • Tumor Necrosis Factor-alpha
  • Imipenem
  • Ceftazidime